Evoke plc (LON:EVOK - Get Free Report) traded down 18.7% on Thursday . The stock traded as low as GBX 56 ($0.72) and last traded at GBX 58.05 ($0.75). 55,595,465 shares changed hands during trading, an increase of 1,853% from the average session volume of 2,847,325 shares. The stock had previously closed at GBX 71.40 ($0.92).
Analyst Upgrades and Downgrades
EVOK has been the topic of several research reports. Jefferies Financial Group restated a "buy" rating and issued a GBX 140 ($1.81) price target on shares of Evoke in a research report on Monday, December 16th. Berenberg Bank dropped their price objective on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a "buy" rating for the company in a report on Wednesday, December 4th.
Get Our Latest Analysis on EVOK
Evoke Stock Performance
The stock has a market cap of £211.75 million, a P/E ratio of -1.19 and a beta of 0.84. The firm's 50 day moving average is GBX 68.36 and its 200 day moving average is GBX 63.39.
Evoke (LON:EVOK - Get Free Report) last posted its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. As a group, analysts expect that Evoke plc will post 12.7648305 EPS for the current fiscal year.
Insider Activity
In other Evoke news, insider Andrea Gisle Joosen bought 14,572 shares of the firm's stock in a transaction on Tuesday, January 28th. The shares were acquired at an average cost of GBX 70 ($0.90) per share, with a total value of £10,200.40 ($13,178.81). Insiders own 27.00% of the company's stock.
About Evoke
(
Get Free Report)
Read More
Before you consider Evoke, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.
While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.